For more updates follow
To get global pharma news updates in whatsapp please
Showing posts with label FRESHERS. Show all posts
Showing posts with label FRESHERS. Show all posts
Tuesday, 30 May 2023
SMS PHARMACEUTICALS WALK IN INTERVIEW FOR FRESHERS ON 02nd & 3rd JUNE,2023@ HYDERABAD
About Company :
Shri Ramesh Babu Potluri, Chairman and Managing Director – A Visionary in pharma industry started SMS Pharmaceuticals Ltd in the year 1990 taking over a sick facility and turning it around by changing of products within no time. From a single unit and single product entity SMS grew into multiple facilities and multiple products group having customer base in more than 70 countries.
For more updates follow
Sunday, 26 December 2021
GRANULES INDIA LTD WALK IN INTERVIEW FOR FRESHERS ON 28th, DECEMBER, 2021 @ HYDERABAD
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
Thursday, 28 October 2021
PFIZER HEALTHCARE PVT LTD WALK IN INTERVIEW FOR FRESHERS ON 30th, OCTOBER, ,2021 @ VIZAG
ABOUT COMPANY :
The pursuit of delivering breakthroughs is basic to Pfizer's culture. It shapes our strategy, defines our purpose, and governs every facet of our operations -- from research and development (R&D) that leads to pharmaceutical inventions, to the transfer of knowledge to patients and providers, to the way we respond to the changing marketplace.
Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. And today we're taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis.
Pfizer Limited was listed on the Indian stock exchange in 1966. Today, the company has over one lac shareholders in India. With annual sales of over Rs. 2,000 crores, it is the fourth largest multinational pharmaceutical company in India. The Company has a portfolio of over 150 products across 15 therapeutic areas.
Its top brands include Prevenar 13, Lyrica, Corex – DX, Dolonex, Enbrel, Becosules, Gelusil and Folvite among others. In addition to its commercial operations, Pfizer Limited also operates a state-of-the-art, award-winning manufacturing facility in Goa that produces more than a billion tablets annually.
The Company employs 2,631 colleagues, and is committed to providing therapies to prevent and treat some of the most critical diseases that impact public health in India today.
For more updates follow
To get global pharma news updates in whatsapp please
Friday, 17 September 2021
GRANULES INDIA LTD WALK IN INTERVIEW FOR FRESHERS ON 18th, SEPTEMBER, 2021 @ HYDERABAD
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
Monday, 2 August 2021
JODAS EXPOIM PVT LTD WALK IN INTERVIEWFOR FRESHERS (M.PHARMACY/ B.PHARMACY/ M.Sc) ON 4th, AUGUST, 2021 @ SIDDIPET, TELANGANA
ABOUT COMPANY :
Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
Jodas focuses its operations on four speciality therapeutic segments:
· Anti Infectives (Injectables & Orals)
· Anti Cancer (Injectables & Orals)
· Contrast Media – Injectables
· Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.
Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.
For more updates follow
To get global pharma news updates in whatsapp please
Saturday, 31 July 2021
HETERO LABS LTD WALK IN INTERVIEW FOR FRESHERS ON 1st, AUGUST, 2021 @ HYDERABAD
ABOUT COMPANY :
Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients (APIs) in the world.
Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, which has been approved by top pharma regulatory bodies of the world. Our portfolio includes 300+ products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology etc. Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.
Over the years, Hetero has established its strong leadership in ARVs and Antiviral therapies and caters to 40% of existing global demand for Anti-Retroviral (ARV) APIs and Finished Dosage Forms (FDFs) used in HIV/AIDS treatment.
A track record of responding to Global Public Health Emergencies
The highlight of Hetero’s 27+ years of existence has been its responsive actions to mitigate pandemics and life-threatening diseases afflicting communities across the world. By partnering with innovators for developing Oseltamivir to fight against Swine Flu Pandemic to enabling access to affordable Hepatitis C medicines in underdeveloped countries, Hetero has always endeavoured to do its bit at times of global health crises and save precious lives.
Since the onset of the Covid-19 pandemic, Hetero has been proactive in responding to the various challenges surrounding it. It has been the first company to launch the licensed version of generic Remdesivir under the brand name ‘Covifor’ in India for treating severely infected patients and followed it up with Favipiravir (Favivir) to provide succor to those affected by mild and moderate symptoms. As of today, the company is among the largest manufacturers of Remdesivir globally.
Illustrating its continuing commitment to play its part in the global fight against the pandemic, Hetero has entered into an agreement with the Russian Direct Investment Fund (RDIF) as a manufacturing partner for producing 100 million doses of the Sputnik V vaccine per year. This development also showcases Hetero’s enduring spirit of collaboration and penchant for contributing to global health and well-being.
For more updates follow
To get global pharma news updates in whatsapp please
GRANULES INDIA LTD WALK IN INTERVIEW FOR FRESHERS TO QC DEPARTMENT ON 02nd, AUGUST, 2021 @ HYDERABAD
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
ADMIRON LIFE SCIENCES PVT LTD WALK IN INTERVIEW FOR FRESHERS ON 4th, 5th, AUGUST, 2021 @ VIZAG
ABOUT COMPANY :
Admiron Life Sciences Private Limited is API (Active Pharmaceutical Ingredients) manufacturing facility.
"Admiron Life is a unique API and Advance Intermediates manufacturer; approved and admired by many regulatory authorities and customers globally. We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry."
Admiron Life established in 2010 by a team of scientists who had a passion towards chemistry & to ensure a better health to everyone.
Well-equipped standalone Research and Development lab with 15 professional scientists with strong knowledge of chemistry.
Admiron Life is committed to maintain best Quality standards in Research & Development and Manufacturing of pharmaceutical products...
WALK IN DETAILS :
Walk-in Interviews for R&D /QC Freshers @ Visakhapatnam
Admiron Life Sciences Pvt. Ltd. is an APIs manufacturer, looking for suitable candidate for Visakhapatnam Unit.
Department : R&D/QC (Bulk Drugs /API Experience)
Position: Trainee Chemist
Experience : Freshers
Qualification: M. Sc Organic chemistry
Job Location: Visakhapatnam
Interview Venue:
Admiron Life Sciences Pvt Ltd
Plot no: 11 JNPC, Parawada,
Visakhapatnam Dt,
AP, India-531019,
Contact: A. Poleswarrao
Executive HR
Mobile: +91 79958 33388
Date & Time:
August 4 and 5, 2021(Wednesday, Thursday) @ 10:00 AM – 02:00 PM
Note: Male candidates are preferred, willing to join immediately and also willing to work in Shifts.
Candidates has to Carry:
1) Updated Resume.
2) Education Certificates
Candidates who are unable to attend the interview can send Profiles to Email:
For more updates follow
To get global pharma news updates in whatsapp please
Friday, 30 July 2021
JODAS EXPOIM PVT LTD WALK IN INTERVIEW FOR FRESHERS (M.PHARMACY/ B.PHARMACY/ M.Sc) ON 31st, JULY, 2021 @ SIDDIPETA, TELANGANA
ABOUT COMPANY :
Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
Jodas focuses its operations on four speciality therapeutic segments:
· Anti Infectives (Injectables & Orals)
· Anti Cancer (Injectables & Orals)
· Contrast Media – Injectables
· Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.
Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.
For more updates follow
To get global pharma news updates in whatsapp please
AURORE LIFE SCIENCES INVITING APPLICATIONS FOR FRESHERS @ HYDERABAD
ABOUT COMPANY :
Established in 2017, We are a pure-play Active Pharmaceutical Ingredient (API) company keen on delivering superior products in a regulatory compliant environment.
We are backed up with manufacturing facilities in India with a combined manufacturing capacity of 600 KL and our flagship facility in Hyderabad in approved with USFDA, EDQM, WHO Geneva, COFEPRIS, KFDA amongst other regulatory agencies. Our facilities, coupled with a dedicated R&D setup, complement our strategy to be a fully integrated API company with complete control of key starting materials, advanced intermediates and high-quality final product.
With a strong team of R&D experts that complements our strategy, Aurore is rapidly emerging as the most preferred API and key API intermediates supply partner for leading global pharmaceutical companies.
With a robust portfolio of niche and differentiated molecule spread across major therapeutic divisions, we are rapidly establishing ourselves as a reliable partner to serve unmet demands of the market.
Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.
For more updates follow
To get global pharma news updates in whatsapp please
Wednesday, 28 July 2021
GRANULES INDIA LTD WALK IN INTERVIEW FOR FRESHERS ON 29th, JULY, 2021 @ HYDERABAD
ABOUT COMPANY :
Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.
As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.
For more updates follow
To get global pharma news updates in whatsapp please
Tuesday, 27 July 2021
AUROBINDO PHARMA HIRING FRESHERS (M.PHARMACY) FOR R&D DEPARTMENT @ HYDERABAD
ABOUT COMPANY :
Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.
Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.
VACANCY DETAILS :
For more updates follow
To get global pharma news updates in whatsapp please
VITAL THERAPEUTICS PVT LTD WALK IN INTERVIEW FOR FRESHERS & EXPERIENCE ON 31st, JULY, 2021@ HYDERABAD
ABOUT COMPANY :
Vital Therapeutics & Formulations Private Limited is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes.
The company was founded in the year 2004 and promoted by Mr. S. Venugopal & Mr.Ramesh Babu to become one of the pioneers in the industry led by their polished expertise and high profile entrepreneurial talent. Through their vision, perseverance and a talented management team, the company is skilled at providing a wide range of services to cater to the prerequisites of national and international pharma majors. Various members of the team bring with them a strong work ethic, commitment to hard-work, professional knowledge and fresh perspective that catapults the company to success in all fields of operations.
We are looking for competent, dynamic and motivated candidates for suitable positions.
For more updates follow
To get global pharma news updates in whatsapp please
COLUMBIA ASIA HOSPITALS HIRING PHARMACISTS (D.PHARMA / B.PHARMACY) @ HEBBAL , KARNATAKA
For more updates follow
To get global pharma news updates in whatsapp please
BRILLIANT BIO PHARMA WALK IN INTERVIEW ON 01 st, AUGUST, 2021@ PHARMA PATASHALA, MIYAPUR, HYDERABAD
Greetings from Pharma Patashala
Walk In Interview On 01/08/2021 at Pharma Patashala
Organization: Brilliant Bio Pharma
Department: PRODUCTION,
Qualification: B.Sc, Experience: Freshers
Department:QC/ QA
Qualification: B.Sc /B.Pharm , Experience: Freshers
Department:Quality Assurance
Designation: Manager, Qualification: M.Pharm
Experience: 10 to 12 years in Bio industry. Salary: 10 to 12 lakhs
Department: Quality Control
Designation: Manager , Qualification: M.Sc Microbiology
Experience: 10 to 12 years in Bio Industry, Salary: 10 to 12 lakhs
Interview Venue:
THE PHARMA PATASHALA,
Above Reliance fresh
1st floor , IDA Bollaram Road
Miyapur, Hyderabad.
Mobile Numbers:
9000723902,040 40125050
9652197755, 9949197755.
Send resumes to : hr@pharmapatashala.com
For more updates follow
To get global pharma news updates in whatsapp please
ARAGEN LIFE SCIENCES (GVK BIO COMPANY) HIRING FRESHERS FOR Synthesis Chemistry Solutions (Discovery) @ BANGALORE
ABOUT COMPANY :
Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health.
Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.
At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.
The Year 2021 is a defining milestone on our journey so far. It marks the 20th anniversary of GVK BIO’s resilient growth story and its transformation into Aragen, a trusted R&D and manufacturing partner to the global life sciences industry. With Aragen, we unveil a new brand identity, an inspiring purpose, and a promise to customers
VACANCY DETAILS :
We are hiring for Synthesis Chemistry Solutions (Discovery)
Job Role
• Executing chemical reactions to synthesize required quantities of molecules/ compounds as per client specifications using efficient route and techniques
• Set-up and execute reactions for synthesis of target molecules/compounds mg level
Requirements
-Freshers-PhD Organic chemistry/Medicinal chemistry/Synthesis Organic Chemistry related
Experience level: Freshers 2019/2020/2021 Passed out
Please email your cv to raghuveera.vutla.c@aragen.com
Job Location: Bangalore (Karnataka)
Note: Immediate Joinees Preferred...
For more updates follow
To get global pharma news updates in whatsapp please
JODAS EXPOIM PVT LTD WALK IN INTERVIEW FOR FRESHERS & EXPERIENCE CANDIDATES FOR R&D ON 28 th, JULY, 2021 @ SIDDIPETA , TELANGANA
ABOUT COMPANY :
Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.
Jodas focuses its operations on four speciality therapeutic segments:
· Anti Infectives (Injectables & Orals)
· Anti Cancer (Injectables & Orals)
· Contrast Media – Injectables
· Critical Care (Injectables & Orals)
Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.
Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.
Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.
Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.
We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.
Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.
For more updates follow
To get global pharma news updates in whatsapp please
Subscribe to:
Posts (Atom)